Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-22-021981
Filing Date
2022-06-10
Accepted
2022-06-10 17:40:21
Documents
1
Period of Report
2022-06-09

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4979
  Complete submission text file 0000899243-22-021981.txt   6357
Mailing Address 662 ENCINITAS BLVD., STE. 250 ENCINITAS CA 92024
Business Address 662 ENCINITAS BLVD., STE. 250 ENCINITAS CA 92024 (858) 945-2393
Ventyx Biosciences, Inc. (Issuer) CIK: 0001851194 (see all company filings)

EIN.: 832996852 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ELEVATION ONCOLOGY, INC. 888 SEVENTH AVENUE, 12TH FLOOR NEW YORK NY 10106
Business Address
Gaster Richard (Reporting) CIK: 0001866026 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40928 | Film No.: 221010057